Related Experiment Video
Updated: Aug 6, 2025

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
Published on: January 26, 2024
Integrative Medicine for Ovarian Cancer
Eran Ben-Arye1,2, Ofer Lavie3, Wolfgang Heyl4
1Integrative Oncology Program, The Oncology Service, Lin, Carmel & Zebulun Medical Centers, Clalit Health Services, Haifa, Western Galilee District, Israel. eranben@netvision.net.il.
Integrative oncology (IO) offers complementary therapies to enhance ovarian cancer care. Further research is needed to establish clinical guidelines for IO effectiveness and safety in gynecological oncology.
Area of Science:
- Gynecological Oncology
- Integrative Medicine
- Complementary Therapies
Background:
- Integrative oncology (IO) services offer complementary therapies.
- These therapies can enhance conventional supportive and palliative care for ovarian cancer patients.
Purpose of the Study:
- To assess the current state of integrative oncology research in ovarian cancer care.
- To review clinical research on the effectiveness and safety of leading IO modalities.
Main Methods:
- Review of clinical research on integrative oncology interventions for ovarian cancer.
- Analysis of studies supporting IO effectiveness and safety concerns.
Main Results:
- Growing clinical research supports the use of IO in gynecological oncology.
- Implementation of integrative gynecological oncology models is increasing.
Conclusions:
- Additional research is required to develop clinical guidelines for IO in ovarian cancer.
- Guidelines must address effectiveness and safety for oncology professionals.
Related Concept Videos
Treatment Resistant Cancers
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

